Lytix Biopharma among 11 finalists at the third annual Lyfebulb-Helsinn Innovation Summit
We are pleased to share that we are among the 11 finalists participating in the third annual Lyfebulb-Helsinn Innovation Summit (in Monaco, January 29-30).
The Lyfebulb-Helsinn Innovation Award will be presented to an exceptional innovator with outstanding entrepreneurial potential to commercialize a creative idea to better manage cancer using drugs, medical devices or healthcare information technology.